Status:
COMPLETED
Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40+ years
Brief Summary
To obtain further information on the prescribing pattern and therapeutic long term value in patients suffering from moderate or severs Chronic Obstructive Pulmonary Disease under conditions of daily p...
Eligibility Criteria
Inclusion
- Patients of both genders older than 40 years, who suffer from moderate or severe Chronic Obstructive Pulmonary Disease
- Only patients who showed following diagnosis parameters were to be considered for inclusion
- FEV1 (Forced expiratory volume in 1 second) and FEV1/VC (vital capacity) \<70%
- Reversibility FEV1 \<12% in the last 6 months
- Smoker or Ex-smoker (\>10 Pack years)
- Asthma to be excluded
Exclusion
- • Contraindications listed in the Instructions for Use/Summary of Product Characteristics
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT02238184
Start Date
January 1 2001
Last Update
September 12 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.